Brazil to buy 20 million doses of Bharat Biotech Covaxin

Published On 2021-02-28 04:45 GMT   |   Update On 2021-02-28 04:45 GMT
Advertisement

Brasilia: Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery between March and May.

The ministry said in a statement that the deal is worth 1.6 billion reais ($290,000), with the first 8 million doses expected to arrive in March.
To speed up the buying of vaccines in Brazil and deal with the second-deadliest coronavirus outbreak in the world, the ministry said it published new rules last week dispensing with the bidding process.
Brazil reported 1,541 new Covid-19 deaths on Thursday, the second highest daily death toll since the pandemic began, taking total fatalities to 251,498.
With 65,998 new cases, the South American country has now registered 10,390,461 cases, the world's third worst outbreak behind the United States and India.


Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News